The semaphorin 3A/neuropilin-1 pathway promotes clonogenic growth of glioblastoma via activation of TGF-β signaling
Authors:
- Hye-Min JeonHJHye-Min Jeon
- Yong Jae ShinYSYong Jae Shin
- Jaehyun LeeJLJaehyun Lee
- Nakho ChangNCNakho Chang
- Dong-Hun WooDWDong-Hun Woo
- Won Jun LeeWLWon Jun Lee
- Dayna NguyenDNDayna Nguyen
- Wonyoung KangWKWonyoung Kang
- Hee Jin ChoHCHee Jin Cho
- Heekyoung YangHYHeekyoung Yang
- Jin-Ku LeeJLJin-Ku Lee
- Jason K. SaJSJason K. Sa
Open Access
- 8 November 2023
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 8 (21)
Abstract
Glioblastoma (GBM) is the most lethal brain cancer with a dismal prognosis. Stem-like GBM cells (GSCs) are a major driver of GBM propagation and recurrence; thus, understanding the molecular mechanisms that promote GSCs may lead to effective therapeutic approaches. Through in vitro clonogenic growth-based assays, we determined mitogenic activities of the ligand molecules that are implicated in neural development. We have identified that semaphorin 3A (Sema3A), originally known as an axon guidance molecule in the CNS, promotes clonogenic growth of GBM cells but not normal neural progenitor cells (NPCs). Mechanistically, Sema3A binds to its receptor neuropilin-1 (NRP1) and facilitates an interaction between NRP1 and TGF-β receptor 1 (TGF-βR1), which in turn leads to activation of canonical TGF-β signaling in both GSCs and NPCs. TGF-β signaling enhances self-renewal and survival of GBM tumors through induction of key stem cell factors, but it evokes cytostatic responses in NPCs. Blockage of the Sema3A/NRP1 axis via shRNA-mediated knockdown of Sema3A or NRP1 impeded clonogenic growth and TGF-β pathway activity in GSCs and inhibited tumor growth in vivo. Taken together, these findings suggest that the Sema3A/NRP1/TGF-βR1 signaling axis is a critical regulator of GSC propagation and a potential therapeutic target for GBM.Keywords
Funding Information
- Clinical Center (NIH R01 CA223370)
This publication has 50 references indexed in Scilit:
- Emerging Role of Semaphorins as Major Regulatory Signals and Potential Therapeutic Targets in CancerCancer Cell, 2012
- Eyes Wide Open: A Critical Review of Sphere-Formation as an Assay for Stem CellsCell Stem Cell, 2011
- TGF-β Receptor Inhibitors Target the CD44high/Id1high Glioma-Initiating Cell Population in Human GlioblastomaCancer Cell, 2010
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1Cancer Cell, 2010
- Autocrine TGF-β Signaling Maintains Tumorigenicity of Glioma-Initiating Cells through Sry-Related HMG-Box FactorsCell Stem Cell, 2009
- TGF-β Increases Glioma-Initiating Cell Self-Renewal through the Induction of LIF in Human GlioblastomaCancer Cell, 2009
- An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumorsNature Genetics, 2008
- Transforming growth factor-β gene expression signature in mouse hepatocytes predicts clinical outcome in human cancerHepatology, 2008
- Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathwayOncogene, 2007
- Glioma stem cells promote radioresistance by preferential activation of the DNA damage responseNature, 2006